Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial

Objective: To evaluate effects of atrial fibrillation (AF) on cardiac biomarkers and outcomes in a trial population of patients with heart failure (HF) with reduced ejection fraction treated with optimal guideline-directed medical therapy. Methods: We performed a secondary analysis of 894 patients i...

Full description

Bibliographic Details
Main Authors: Fouad Chouairi, BS, Justin Pacor, MD, P. Elliott Miller, MD, Michael A. Fuery, MD, Cesar Caraballo, MD, Sounok Sen, MD, Eric S. Leifer, PhD, G. Michael Felker, MD, MHS, Mona Fiuzat, PharmD, Christopher M. O’Connor, MD, James L. Januzzi, MD, Daniel J. Friedman, MD, Nihar R. Desai, MD, MPH, Tariq Ahmad, MD, MPH, James V. Freeman, MD, MPH, MS
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454821000382

Similar Items